Allogeneic Peripheral Stem Cell Transplantation in Treating Patients With Stage IV Breast Cancer
Status:
Completed
Trial end date:
2007-08-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Peripheral stem cell transplantation may be able to replace immune cells that were
destroyed by chemotherapy used to kill tumor cells.
PURPOSE: Phase II trial to study the effectiveness of allogeneic peripheral stem cell
transplantation in treating patients who have stage IV breast cancer.